NCT02194296View on ClinicalTrials.gov

Relative Bioavailability of Ambroxol Hydrochloride Lozenge in Comparison to Ambroxol Hydrochloride Syrup (Mucosolvan®) in Healthy Female and Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 30, 1999

Primary Completion Date

July 31, 1999

Conditions
Healthy
Interventions
DRUG

Ambroxol hydrochloride - lozenge

DRUG

Ambroxol hydrochloride - syrup

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02194296 - Relative Bioavailability of Ambroxol Hydrochloride Lozenge in Comparison to Ambroxol Hydrochloride Syrup (Mucosolvan®) in Healthy Female and Male Volunteers | Biotech Hunter | Biotech Hunter